May 19, 2016

The drug is a first-in-class treatment for urothelial carcinoma, the most common type of bladder cancer.

May 16, 2016

The Food and Drug Administration on Friday approved a new indication for Eisai’s Lenvima (lenvatinib). 

May 16, 2016

The agreement will allow pharmacies to provide full-service specialty offerings for patients with complex chronic conditions and it will see Diplomat providing 24/7 access to specialty pharmacists and technicians.

May 13, 2016

According to the Alliance for Safe Biologic Medicines, the letter was spurred by the agency choosing a random suffix when it approved the second biosimilar earlier this year.

May 13, 2016
The acquisition will bring Mylan some 25 branded and generic topical products alongside a pipeline of another 25 potential products.
May 12, 2016

Benzer Pharmacy CEO Alpesh Patel said the company specializes in specialty pharmacy while offering management programs to patients with complex chronic diseases. 

May 9, 2016

A new report from PhRMA and the ALS Association is looking in-depth at the more than 560 drugs being developed that take new approaches to disease targeting. 

May 4, 2016

The findings underscore the value of home infusion services – where medication is delivered intravenously in a patient's home – for the health care system, including patients and payers.

May 3, 2016

Due partly to its small patient population, Taro said Keveyis has seen less than $1 million in sales since its launch, making the investment in marketing the drug unsustainable.

April 29, 2016

The deal will see the nation’s largest independent specialty pharmacy acquiring the seven-year-old oncology-focused company for $75 million, a mixture of cash and about 328,000 shares of Diplomat stock.

April 28, 2016

Biopharmaceutical company AbbVie on Thursday announced its planned acquisition of Stemcentrx and its late-stage potential treatment for small cell lung cancer, Rova-T. 

April 28, 2016

The donations were inspired by a 13-hour, nearly 600-mile overnight truck delivery to provide lifesaving treatment to a newborn at a Toronto hospital on Christmas Day, 2015.

April 28, 2016

RxCrossroads, a subsidiary of CVS Health, unveiled plans for significant expansion of its distribution center in Louisville, Ky., the Courier-Journal, a USA Today publication, reported Thursday. Acquired in 2005 by Omnicare and later in 2015 by CVS Health, RxCrossroads offers a portfolio of specialty distribution, pharmacy and patient support services. Anticipating a surge in customer demand, the company has laid out plans for an $11 million building, with $8.7 million in equipment and $600,000 in additional startup costs, the Courier-Journal reported. (Courier-Journal

April 27, 2016

Before she joined Diplomat, Hagerman was an associate professor at the Ferris State University College of Pharmacy with a practice site at Hurley Medical Center.

April 27, 2016

Lorrie Carr will oversee ZappRx’s commercialization efforts as it launches and looks to expand its specialty prescribing and management platform. 

April 26, 2016
SILVER SPRING, Md. — The Food and Drug Administration has approved Exelixis’ Cabometyx (cabozantinib) tablets, the company announced this week. Cabometyx is indicated to treat patients with advanced renal cell carcinoma who have previously received anti-angiogenic treatment.   
April 25, 2016
The new indication for Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets; dasabuvir tablets) will allow it to be used for patients with genotype 1b chronic hepatitis C and compensated cirrhosis. 
April 21, 2016

AbbVie and the University of Chicago announced this week a new five-year collaboration to advance oncology medical research and improve the pace of discovery for both organizations.

April 20, 2016
The once-daily oral therapy had previously been approved as a first-line treatment for specific types of non-small cell lung cancer. 
April 14, 2016

DSN examines chain pharmacy, including in-depth coverage of specialty pharmacy, orphan drugs and biosimilars, in this multi-page report.


April 13, 2016

Biologic medications — nine of which were among the Food and Drug Administration’s approvals in 2015 — constitute a big portion of the specialty market.

April 13, 2016

In the last two years, the FDA has broken its record for the approval of orphan drugs to treat diseases that affect 200,000 or fewer people.

April 13, 2016

In this issue, Drug Store News previews its DSN 2016 Yearbook, featuring our annual PoweRx company profiles. The full report will be available this summer with exclusive company rankings and profiles of every company in our Top 50. Two strong examples are Ritzman Pharmacy and Benzer Pharmacy — two small chains that are big on innovation and growing their businesses in unique ways.

April 13, 2016

It’s no secret that the category of drugs drawing the most attention — and money — in recent years has been specialty pharmacy.